| Compound genetic ablation of nidogen 1 and 2 causes basement membrane defects and perinatal lethality in mice BL Bader, N Smyth, S Nedbal, N Miosge, A Baranowsky, S Mokkapati, ... Molecular and cellular biology 25 (15), 6846-6856, 2005 | 281 | 2005 |
| Nidogens—Extracellular matrix linker molecules MSP Ho, K Böse, S Mokkapati, R Nischt, N Smyth Microscopy research and technique 71 (5), 387-395, 2008 | 148 | 2008 |
| β-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma S Mokkapati, K Niopek, L Huang, KJ Cunniff, EC Ruteshouser, ... Cancer research 74 (16), 4515-4525, 2014 | 88 | 2014 |
| Epidermal transglutaminase (TGase 3) is required for proper hair development, but not the formation of the epidermal barrier S John, L Thiebach, C Frie, S Mokkapati, M Bechtel, R Nischt, ... PLoS One 7 (4), e34252, 2012 | 73 | 2012 |
| Basement membranes in skin are differently affected by lack of nidogen 1 and 2 S Mokkapati, A Baranowsky, N Mirancea, N Smyth, D Breitkreutz, R Nischt Journal of Investigative Dermatology 128 (9), 2259-2267, 2008 | 62 | 2008 |
| Lack of nidogen-1 and-2 prevents basement membrane assembly in skin-organotypic coculture R Nischt, C Schmidt, N Mirancea, A Baranowsky, S Mokkapati, N Smyth, ... Journal of Investigative Dermatology 127 (3), 545-554, 2007 | 55 | 2007 |
| Impaired wound healing in mice lacking the basement membrane protein nidogen 1 A Baranowsky, S Mokkapati, M Bechtel, J Krügel, N Miosge, ... Matrix Biology 29 (1), 15-21, 2010 | 46 | 2010 |
| Pim kinase isoforms: devils defending cancer cells from therapeutic and immune attacks GG Jinesh, S Mokkapati, K Zhu, EE Morales Apoptosis 21, 1203-1213, 2016 | 35 | 2016 |
| Nephron progenitor but not stromal progenitor cells give rise to Wilms tumors in mouse models with β-catenin activation or Wt1 ablation and Igf2 upregulation L Huang, S Mokkapati, Q Hu, EC Ruteshouser, MJ Hicks, V Huff Neoplasia 18 (2), 71-81, 2016 | 31 | 2016 |
| Absence of the basement membrane component nidogen 2, but not of nidogen 1, results in increased lung metastasis in mice S Mokkapati, M Bechtel, M Reibetanz, N Miosge, R Nischt Journal of Histochemistry & Cytochemistry 60 (4), 280-289, 2012 | 30 | 2012 |
| The development of interferon-based gene therapy for BCG unresponsive bladder cancer: from bench to bedside JJ Duplisea, S Mokkapati, D Plote, KS Schluns, DJ McConkey, ... World journal of urology 37, 2041-2049, 2019 | 24 | 2019 |
| Basement membrane deposition of nidogen 1 but not nidogen 2 requires the nidogen binding module of the laminin γ1 chain S Mokkapati, A Fleger-Weckmann, M Bechtel, M Koch, D Breitkreutz, ... Journal of biological chemistry 286 (3), 1911-1918, 2011 | 21 | 2011 |
| Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non–muscle-invasive Bladder Cancer: Secondary Analysis of a Phase … AP Mitra, VM Narayan, S Mokkapati, T Miest, SA Boorjian, M Alemozaffar, ... European urology 81 (3), 223-228, 2022 | 12 | 2022 |
| Inhibition of urothelial carcinoma through targeted type I interferon-mediated immune activation D Plote, W Choi, S Mokkapati, D Sundi, JE Ferguson III, J Duplisea, ... Oncoimmunology 8 (5), e1577125, 2019 | 12 | 2019 |
| TCF21 promotes luminal-like differentiation and suppresses metastasis in bladder cancer S Mokkapati, SP Porten, VM Narayan, AH Lim, IS Jayaratna, B Roth, ... Molecular Cancer Research 18 (6), 811-821, 2020 | 7 | 2020 |
| Effects of thiazolidinedione in patients with active bladder cancer R Li, MJ Metcalfe, JE Ferguson 3rd, S Mokkapati, GM Nogueras González, ... BJU international 121 (2), 244-251, 2018 | 7 | 2018 |
| Interferon gene therapy with nadofaragene firadenovec for bladder cancer: from bench to approval A Martini, C Tholomier, S Mokkapati, CPN Dinney Frontiers in immunology 14, 1260498, 2023 | 5 | 2023 |
| The current status of gene therapy in bladder cancer C Tholomier, A Martini, S Mokkapati, CP Dinney Expert review of anticancer therapy 23 (5), 531-543, 2023 | 5 | 2023 |
| Generation of a novel mouse strain with conditional, cell‐type specific, expression of DND1 L Nunez, S Mokkapati, C Yu, JM Deng, RR Behringer, A Matin genesis 57 (11-12), e23335, 2019 | 4 | 2019 |
| Lentiviral interferon: A novel method for gene therapy in bladder cancer S Mokkapati, VM Narayan, GC Manyam, AH Lim, JJ Duplisea, ... Molecular Therapy-Oncolytics 26, 141-157, 2022 | 3 | 2022 |
